BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17291746)

  • 1. Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
    Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP
    Eur J Cancer; 2007 Apr; 43(6):979-92. PubMed ID: 17291746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence.
    Singhal A; Jayaraman M; Dhanasekaran DN; Kohli V
    Crit Rev Oncol Hematol; 2012 May; 82(2):116-40. PubMed ID: 21680198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
    Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
    Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
    Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
    J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic molecular markers in hepatocellular carcinoma.
    Qin LX; Tang ZY
    World J Gastroenterol; 2002 Jun; 8(3):385-92. PubMed ID: 12046056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.
    Liu X; Zhou J; Zhou N; Zhu J; Feng Y; Miao X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):115. PubMed ID: 27440153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in hepatocellular carcinoma.
    Liu LN; Li DD; Xu HX; Zheng SG; Zhang XP
    Front Biosci (Landmark Ed); 2015 Jun; 20(7):1056-67. PubMed ID: 25961544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
    Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
    Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 14. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
    Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
    Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
    Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
    PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
    Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
    Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.